Shandong Bailong Chuangyuan Hits Day High with 5.05% Surge in Stock Price

Shandong Bailong Chuangyuan Bio-Tech Co., Ltd. has shown significant activity today, achieving a notable gain of 5.05% on October 13, 2025. The stock reached an intraday high of CNY 21.65, reflecting its strong performance in the market.
Over the past year, Shandong Bailong has outperformed the China Shanghai Composite, generating a return of 49.31% compared to the index's 18.02%. The company's robust financial metrics include a return on equity (ROE) of 16.38% and a price-to-book ratio of 4.73, indicating a fair valuation relative to its assets.

In terms of operational performance, Shandong Bailong has reported positive results for the last four consecutive quarters, with net sales reaching CNY 336.46 million and operating cash flow peaking at CNY 273.58 million. The company has demonstrated a strong growth trajectory, with a year-to-date performance of 66.31%, further solidifying its position in the FMCG sector.

As a mid-cap company with a market capitalization of CNY 8,539 million, Shandong Bailong continues to exhibit resilience and growth potential in a competitive market landscape.